DE NICOLA, Luca
 Distribuzione geografica
Continente #
EU - Europa 20.416
NA - Nord America 11.466
AS - Asia 9.284
SA - Sud America 1.460
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 42.768
Nazione #
RU - Federazione Russa 13.409
US - Stati Uniti d'America 11.313
SG - Singapore 3.194
IE - Irlanda 2.179
CN - Cina 2.060
HK - Hong Kong 1.514
BR - Brasile 1.225
UA - Ucraina 1.169
GB - Regno Unito 935
VN - Vietnam 896
IT - Italia 853
DE - Germania 669
IN - India 513
TR - Turchia 333
FI - Finlandia 321
KR - Corea 303
SE - Svezia 299
GR - Grecia 188
JP - Giappone 112
FR - Francia 107
AR - Argentina 96
BD - Bangladesh 94
CA - Canada 70
AT - Austria 58
NL - Olanda 47
MX - Messico 46
BE - Belgio 43
EC - Ecuador 40
IQ - Iraq 36
ZA - Sudafrica 33
ES - Italia 31
PK - Pakistan 31
CZ - Repubblica Ceca 30
ID - Indonesia 28
CO - Colombia 24
MA - Marocco 21
TN - Tunisia 21
VE - Venezuela 20
PH - Filippine 19
CL - Cile 17
IR - Iran 17
MY - Malesia 17
UZ - Uzbekistan 16
PL - Polonia 15
PY - Paraguay 15
SA - Arabia Saudita 13
IL - Israele 11
JM - Giamaica 11
KE - Kenya 11
KZ - Kazakistan 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
UY - Uruguay 9
EG - Egitto 8
EU - Europa 8
PE - Perù 8
TH - Thailandia 8
HU - Ungheria 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
NP - Nepal 5
OM - Oman 5
RS - Serbia 5
SC - Seychelles 5
CI - Costa d'Avorio 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
LB - Libano 4
NI - Nicaragua 4
PT - Portogallo 4
BG - Bulgaria 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RW - Ruanda 2
SI - Slovenia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UG - Uganda 2
Totale 42.741
Città #
Moscow 4.773
Dublin 2.177
Jacksonville 1.751
Santa Clara 1.544
Hong Kong 1.508
Singapore 1.283
Chandler 1.119
San Jose 1.117
Chicago 488
Ashburn 478
Bengaluru 441
Princeton 343
Hefei 316
Ho Chi Minh City 309
Seoul 289
Medford 279
Wilmington 269
Beijing 237
Hanoi 212
Roxbury 210
Boardman 209
Dallas 207
Ann Arbor 168
San Mateo 157
New York 146
Falls Church 133
The Dalles 126
Woodbridge 118
São Paulo 113
Naples 105
Istanbul 96
Munich 96
Los Angeles 87
Cambridge 85
Des Moines 80
Bremen 75
Nanjing 69
Jinan 62
Caserta 56
Da Nang 54
Rio de Janeiro 46
Brussels 42
Milan 42
Nuremberg 42
Norwalk 41
Houston 40
Rome 39
Haiphong 38
Mountain View 35
Shenyang 35
Belo Horizonte 34
Napoli 33
Zhengzhou 33
Saint Petersburg 32
Guangzhou 30
Orem 30
Vienna 28
Brno 27
Frankfurt am Main 25
Tianjin 24
Helsinki 23
Shanghai 23
Changsha 21
Council Bluffs 21
Tokyo 21
Biên Hòa 20
Brooklyn 20
Curitiba 20
Düsseldorf 19
Ercolano 19
Hangzhou 19
Hải Dương 19
Ningbo 19
Atlanta 18
Chennai 18
Nanchang 18
Taizhou 18
Campinas 17
London 17
Quito 17
San Francisco 17
Turku 17
Johannesburg 16
Sorocaba 15
Taiyuan 15
Amsterdam 14
Bologna 14
Buenos Aires 14
Dhaka 14
Falkenstein 14
Lanzhou 14
Phoenix 14
Toronto 14
Porto Alegre 13
Seattle 13
Thái Bình 13
Auburn Hills 12
Boston 12
Haikou 12
Jiaxing 12
Totale 22.747
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 834
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 235
Empagliflozin in Patients with Chronic Kidney Disease 228
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 204
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 191
Amino acid loss during dialysis treatment 179
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 176
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 176
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 174
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 173
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 172
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 172
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 170
[Anti-diabetics and chronic kidney disease] 170
[Hyperuricaemia and Chronic Kidney Disease] 168
[Iron deficiency in ND-CKD: from diagnosis to treatment] 167
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 164
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 164
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 163
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 161
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 161
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 160
Daily nutrient intake in hemodialysis. 158
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 158
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 156
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 156
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 155
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 155
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 153
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 153
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 152
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 152
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 152
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 151
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 151
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 151
[Epidemiology and prognosis of chronic kidney disease in Italy] 151
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 151
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 149
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 148
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 147
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 145
Acute cyclosporine A nephrotoxicity 145
A new diuretic: the Atrial Natriuretic Peptide 144
Acute renal and immunological effects of low-dose cyclosporin in humans 143
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 143
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 142
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 140
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 140
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 140
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 139
Disfunzione renale nell’anziano: processo fisiologico o malattia? 139
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 138
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 138
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 137
Epidemiology of chronic kidney disease in Italy: the CARHES study 137
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 137
Epidemiology of CKD Regression in Patients under Nephrology Care 137
Acute effects of low-dose cyclosporine on renal function in normal subjects 135
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 135
Management of hypertension in chronic kidney disease: the Italian multicenter study. 134
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 134
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 134
Renal Disease 134
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 134
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 133
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 132
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 132
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 132
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 131
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 131
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 131
Anemia: A Connection Between Heart Failure and Kidney Failure 131
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 129
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 129
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 129
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 129
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics 129
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 129
Sodium intake and chronic kidney disease 129
Management of hypertension in chronic kidney disease 128
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 128
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 127
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 127
Epidemiology of chronic kidney disease in Italy 127
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 126
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 126
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 126
Heart Failure in chronic kidney disease: from epidemiology to therapy. 126
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. 126
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 126
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 126
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 126
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 125
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 124
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 124
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 124
Are all erythropoiesis-stimulating agents created equal? 124
Totale 15.257
Categoria #
all - tutte 147.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/20222.291 188 42 43 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/202622.714 887 1.204 1.168 1.078 1.769 12.565 1.170 983 881 563 326 120
Totale 43.224